EUS5WisdomTree Long USD Short EUR 5x Daily
ISIN: JE00BMM1XC770,98%
Management Fee (MER)
Au 03.07.2026
22 septembre 2014
Date de lancement
4 096 063 $US
AUM du fonds
Au 03.07.2026
EUR
Devise de base
Vue d'ensemble
Description du produit
WisdomTree Long USD Short EUR 5x Daily is a fully collateralised, UCITS eligible Exchange Traded Product (ETP) designed to provide investors with a leveraged exposure to USD relative to EUR. The ETP tracks the MSFXSM 5X Long US Dollar/Euro Total Return Index (MSCEEUXL), providing a total return comprised of 5 times the daily performance of FX forward contracts being Long USD relative to EUR, plus the interest revenue adjusted to reflect fees and costs associated with the product. For example, if USD rises by 1% relative to EUR over a day, then the ETP will rise by 5%, excluding fees. However if USD falls by 1% relative to EUR over a day, then the ETP will fall by 5%, excluding fees.
Pourquoi EUS5?
- Gain a Long exposure to USD relative to EUR .
- Magnify your returns in one simple trade.
- UCITS eligible and fully collateralised.
- Transparent performance and fees.
- Easy to invest: Everything in one product which does not require the investor to hold derivatives or a margin account.
- Risk Management: You cannot lose more than the amount invested.
- Liquidity: Trades on exchange, with multiple authorised participants (APs) and market makers (MMs).
Risques potentiels
- An investment in an ETP involves a degree of risk. Any decision to invest should be based on the information contained in the relevant prospectus. Prospective investors should obtain independent accounting, tax and legal advice and should consult their professional advisers to ascertain the suitability of this ETP as an investment to their own circumstances.
- This ETP is structured as a debt security and not as shares (equity) and can be created and redeemed on demand by authorised participants and traded on exchange just like shares in a company. This ETP is not a UCITS product.
- Investing in Short and Leveraged ETPs is only suitable for sophisticated and or informed investors who understand leverage, daily rebalancing and compounded daily returns and are willing to magnify potential losses. Short and Leveraged ETPs are only intended for investors who understand the risks involved in investing in an ETP with short or leveraged exposure and who intend to invest on a short term basis. Any investment in a short or leveraged ETP should be monitored on a daily basis to ensure consistency with your investment strategy. You should understand that investments in daily leveraged ETPs held for a period of longer than the recommended holding period of one day, may not provide returns equivalent to the return from the relevant unleveraged investment multiplied by the relevant leverage factor over the same period. Daily compounding may result in returns which an investor may not expect, if the investor has not fully understood how a daily leveraged ETP works. Potential losses in leveraged ETPs may be magnified in comparison to investments that do not incorporate leverage. In extreme volatility, returns of leveraged ETPs, even over one day, may under-perform the return of the underlying unleveraged index multiplied by the ETP’s leverage factor because of protection mechanisms within the ETP structure, intended to protect against intra-day market crashes. For more information see here.
- Market Risk: The value of securities in this ETP is directly affected by increases and decreases in the value of the Index. Accordingly, the value of a security may go up or down and a security holder may lose some or all of the amount invested but can not lose more than the amount invested.
- Liquidity risk: There can be no certainty that securities can always be bought or sold on a stock exchange or that the market price at which the securities may be traded on a stock exchange will always accurately reflect the performance of the Index.
- Currency Risk: The price of securities in this ETP is generally quoted in EUR. To the extent that a security holder purchases securities in another currency, the value will be affected by changes in the exchange rate.
- Counterparty risk: The Issuer is reliant on there being swap counterparties available to enter into swap agreements on a continuing basis and, if no swap counterparties are willing to do so, the ETP will not be able to achieve its investment policy of tracking the performance of the Index.
- Credit Risk: The Issuer is subject to the risk that third party service providers may fail to return property or collateral belonging to the Issuer or pay money due to the issuer. The ETP is backed by swaps. The payment obligations of the swap counterparties to the Issuer are protected by collateral held which is marked to market daily. The collateral is held in segregated accounts at The Bank of New York Mellon. In the event a swap counterparty defaults, the proceeds from realisation of the collateral may be less than what the investor expects. Details of the collateral held can be found in the Collateral section of the WisdomTree website (www. Wisdomtree. Com).
- Please see the risks factors section of the Prospectus for a more detailed discussion of the potential risks
Informations clés
| Vue d'ensemble du produit | Au 03.07.2026 |
|---|---|
| ISIN | JE00BMM1XC77 |
| Classe d'actifs | FX |
| Devise de base | EUR |
| Date de lancement | 22 septembre 2014 |
| Couvert contre le risque de change | Non |
| Livraison physique disponible | Non |
| Risque sous-jacent | USD/EUR |
| Ticker Bloomberg de l'indice | MSCEEUXL |
| Nom de l'indice | MSFXSM 5X Long US Dollar/Euro Index (TR) |
| Facteur de levier | 5x |
| Valeur liquidative | Au 03.07.2026 |
|---|---|
| NAV | 91.027 $US |
| Variation quotidienne | 0.038 $US |
| Rendement quotidien | 0,042% |
| AUM total du fonds | 4 096 063 $US |
| AUM de l'émetteur | 262 286 828 $US |
| Parts en circulation | 39 324 |
Structure
| Structure | Au 03.07.2026 |
|---|---|
| Forme juridique | Titre de créance |
| Structure juridique | ETP |
| Méthode de réplication | Synthetic - unfunded swap backed by collateral |
| Domiciliation | Jersey |
| Informations juridiques et fiscales complémentaires | Au 03.07.2026 |
|---|---|
| ISA | Eligible |
| SIPP | Eligible |
| Éligible UCITS | Yes |
| Statut de reporting UK | Yes |
| Éligible au PEA | No |
Prestataires de services clés
| Prestataires de services clés | Au 03.07.2026 |
|---|---|
| Émetteur | WisdomTree Foreign Exchange Limited |
| Contrepartie | Morgan Stanley & Co. International plc |
| Fiduciaire | The Law Debenture Trust Corporation p.l.c. |
| Agent de registre | Computershare Investor Services (Jersey) Ltd |
| Gestionnaire du collatéral | The Bank of New York Mellon |
| Frais | Au 03.07.2026 |
|---|---|
| Management Fee (MER) | 0,98% |
| Taux de swap quotidien | 0,002466% |
Pays passeportés
Allocation par pays
| Pays | Poids (%) |
|---|---|
| UNITED STATES | 83,66% |
| GERMANY | 16,34% |
Cotations et codes
| Pays | Bourse | Devise de cotation | Ticker de cotation | Ticker Bloomberg | RIC | SEDOL | ISIN | WKN | Période de règlement | Date de cotation |
|---|---|---|---|---|---|---|---|---|---|---|
| Borsa Italiana | EUR | EUS5 | EUS5 IM | EUS5.MI | BP846T9 | JE00BMM1XC77 | A12Z4E | T + 2 | 25.09.2014 | |
| Xetra | EUR | 5CH5 | 5CH5 GY | 5CH5.DE | BP9LMY6 | JE00BMM1XC77 | A12Z4E | T + 2 | 25.09.2014 |
Index Details
MSFXSM 5X Long US Dollar/Euro Index (TR)
| Index Details | |
|---|---|
| Index Name | MSFXSM 5X Long US Dollar/Euro Index (TR) |
| Currency | EUR |
| Index Provider | Morgan Stanley |
| Bloomberg Ticker | MSCEEUXL |
| Index Website | https://www.morganstanley.com/what-we-do/sales-and-trading/msfx |
| Index Constituent Count | 1 |
| Securities | 03.07.2026 |
|---|---|
| MSFXSM 5X Long US Dollar/Euro Index (TR) | 100,00% |
Collateral Details
| Incorporated Country | Weight |
|---|---|
| UNITED STATES | 83,66% |
| GERMANY | 16,34% |
| Currency | Weight |
|---|---|
| US Dollar | 83,66% |
| Euro | 16,34% |
Documents
Produit
KID
Prospectus
Réglementaire
AVERTISSEMENTS
The products discussed in this document are issued by WisdomTree Foreign Exchange Limited (the "Issuer"). The Issuer is regulated by the Jersey Financial Services Commission. Investors should read the prospectus of the Issuer before investing and should refer to the section of the prospectus entitled ‘Risk Factors’ for further details of risks associated with an investment in the securities offered by the Issuer.
Securities issued by the Issuer are direct, limited recourse obligations of the Issuer alone and are not obligations of or guaranteed by any of Morgan Stanley & Co International plc, Morgan Stanley & Co. Incorporated, any of their affiliates or anyone else or any of their affiliates. Each of Morgan Stanley & Co International plc and Morgan Stanley & Co. Incorporated disclaims all and any liability whether arising in tort, contract or otherwise (save as referred to above) which it might have in respect of this document or its contents otherwise arising in connection herewith.
The Morgan Stanley Indices are the exclusive property of Morgan Stanley & Co. Incorporated ("Morgan Stanley"). Morgan Stanley and the Morgan Stanley index names are service mark(s) of Morgan Stanley or its affiliates and have been licensed for use for certain purposes by WisdomTree Management Jersey Limited in respect of the securities issued by Issuer. The securities issued by Issuer are not sponsored, endorsed, or promoted by Morgan Stanley, and Morgan Stanley bears no liability with respect to any such financial securities. The prospectus of Issuer contains a more detailed description of the limited relationship Morgan Stanley has with Issuer and any related financial securities. No purchaser, seller or holder of securities issued by Issuer, or any other person or entity, should use or refer to any Morgan Stanley trade name, trademark or service mark to sponsor, endorse, market or promote this product without first contacting Morgan Stanley to determine whether Morgan Stanley's permission is required. Under no circumstances may any person or entity claim any affiliation with Morgan Stanley without the prior written permission of Morgan Stanley.